The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling

Peptides
Jiannan FengBeifen Shen

Abstract

The interaction between human interleukin-6 (hIL-6) and human interleukin-6 receptor (hIL-6R) is the initial and most specific step in the hIL-6 signaling pathway. Understanding its binding core and interaction mechanism at amino acid level is the basis for designing small IL-6 inhibiting molecules, such as peptides or lead compounds. With Docking method, the complex structure composed of hIL-6 and its alpha-subunit receptor (hIL-6R) was analyzed theoretically. By using structure-based analysis and phage display methods, the loop AB (from Lys67 to Glu81) of hIL-6 was found to be the important binding epitope of hIL-6R. By means of computer-aided design, the mimic antagonist peptide (14 residues) was designed and synthesized. Using multiple myeloma cell line (XG7), IL-6 dependent cell line, as test model, the influence of antagonist peptides on the proliferation of XG7 cells was investigated. The results showed that the synthetic peptide could be competitive to bind to hIL-6R with hIL-6, and the effect was concentration dependent. The theoretical design approach is a powerful alternative to phage peptide library for protein mimics. Such mini-peptide is more amenable to synthetic chemistry and thus may be useful starting points f...Continue Reading

References

May 25, 1977·Journal of Molecular Biology·F C BernsteinM Tasumi
Feb 1, 1992·Protein Science : a Publication of the Protein Society·R F Doolittle
Jan 1, 1990·Annual Review of Biochemistry·D R DaviesS Sheriff
Sep 15, 1973·Journal of Molecular Biology·A Shrake, J A Rupley
Feb 14, 1971·Journal of Molecular Biology·B Lee, F M Richards
Dec 8, 1995·Science·B LiB C Cunningham
Jan 1, 1993·Advances in Immunology·S AkiraT Kishimoto
Feb 1, 1993·European Journal of Biochemistry·V FontaineG Ciliberto
Mar 5, 1993·Science·B K ShoichetK M Perry
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·A C Braisted, J A Wells
Aug 1, 1996·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M EhlersS Rose-John
Feb 11, 1998·Molecular Neurobiology·D L Gruol, T E Nelson
May 2, 1998·The EMBO Journal·J BravoE Y Jones
Mar 20, 1998·International Reviews of Immunology·T Hirano
Jun 10, 1998·Cytokine & Growth Factor Reviews·T HiranoM Hibi
Mar 30, 1999·Nature Biotechnology·U ReinekeJ Schneider-Mergener
Dec 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·J N VargheseR J Simpson
Jun 28, 2003·Science·Martin J BoulangerK Christopher Garcia

❮ Previous
Next ❯

Citations

Jul 24, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Qingyang WangJiyan Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.